Bank of Montreal
ANRO icon

Bank of Montreal’s Alto Neuroscience ANRO Stock Holding History

Bank of Montreal’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$255K Sell
11,343
-12
-0.1% -$222 ﹤0.01% 2786
2025
Q4 		$202K Buy
11,355
+13
+0.1% +$164 ﹤0.01% 2841
2025
Q3 		$45.6K Hold
11,342
– – ﹤0.01% 3143
2025
Q2 		$25K Buy
+11,342
New +$27K ﹤0.01% 3254

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of Montreal's ANRO Position: Q1 2026 in Review

Bank of Montreal reduced its Alto Neuroscience (ANRO) stake by 0.11% in Q1 2026, selling an estimated $222 and leaving 11,343 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #2786.

Bank of Montreal first reported a position in ANRO in Q2 2025 and has held it in 4 quarters since. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Bank of Montreal held 11,343 shares of Alto Neuroscience worth $255K as of Q1 2026.
  • Bank of Montreal sold 12 Alto Neuroscience shares in Q1 2026, an estimated $222.
  • Alto Neuroscience made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #2786 holding.
  • Bank of Montreal first reported a position in Alto Neuroscience in Q2 2025 and has held it in 4 quarters since.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.